Technology companies are rapidly investing in AI capabilities.
Last week, Oracle Health, Cleveland Clinic and G42, a cloud computing and AI development company based in the United Arab Emirates, announced a partnership to co-develop and launch an AI based healthcare analytics and clinical intelligence platform.
The initial goals for the platform will be to:
- Provide population level health data for systemic analyses on health outcomes
- Understand and help drive cost reductions for health interventions at the individual patient and community levels
- Leverage AI to better harness data and empower clinicians to make better care decisions
- Use data to personalize treatments, improve diagnostic capabilities and even promote better life-sciences research by identifying clinical trial candidates
Though the details are still being ironed out on how the above and more will be executed, the overall vision is to provide a platform through which AI can be leveraged to ultimately improve societal health outcomes.
The partnership brings together three powerhouses in this space.
Oracle Health has grown significantly in the past few years, especially with its renewed commitment to become a leader in the AI race. Since its purchase of Cerner in 2021, the company has doubled down on its healthcare ambitions, specifically to leverage its decades-long experience in building enterprise grade software solutions and data warehousing capabilities to ultimately modernize digital health infrastructure.
Cleveland Clinic has become a household name in the fields of cutting-edge clinical research and care delivery. In the United States, the institution is known for providing world-class care for some of the rarest diseases and conditions. It also opened a campus in Abu Dhabi in 2006 with the goal of bringing world-class clinical care to the UAE. In this partnership, the institution will provide the clinical and care model expertise to build out the larger platform.
Finally, G42 is an Emirati artificial intelligence company, known for its deep investments and involvement in AI projects across a variety of sectors, ranging from healthcare and finance to the oil, gas and hospitality industries. Notably, the chairman of the company is Sheikh Tahnoun bin Zayed Al Nahyan, son of the founder of the UAE and a stalwart in the technology landscape.
These three forces coming together certainly bodes a promising outcome for this venture. Larry Ellison, executive chairman and CTO of Oracle explained that the increasingly complex healthcare landscape requires rethinking the delivery of care; “Together with Cleveland Clinic and G42, we will deliver the modern tools providers need to help people live longer, healthier lives.” Morton C. Mandel, CEO of Cleveland Clinic, adds: “An AI-enabled model of care could positively impact global health systems—a flagship example of how data-driven, tech-powered healthcare can deliver better outcomes, lower costs, and expand access worldwide.”
This partnership is running parallel to the other significant announcements in the AI investment space recently. Specifically, President Trump’s landmark tour of the Middle East last week resulted in significant partnership and deal announcements, including a broader commitment by the UAE for a $1.4 trillion investment to support the building of U.S. AI infrastructure and data centers.
Though more details are forthcoming, the track record of each of these parties separately is well-established. Together, their union will hopefully mold an effective and impactful means to meaningfully improve health outcomes.
